CLEARDAY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.59 USD | -4.84% |
|
+14.56% | -35.87% |
| 04-24 | Clearday Introduces Digital Assistants in Residential Communities | CI |
| 03-21 | Clearday, Inc. announced that it has received $1.464 million in funding from Mast Hill Management, LLC | CI |
| Sales 2021 | 12.88M 1.03B | Sales 2022 | 12.49M 1B | Capitalization | 10.67M 854M |
|---|---|---|---|---|---|
| Net income 2021 | -19M -1.52B | Net income 2022 | -14M -1.12B | EV / Sales 2021 | 6.22 x |
| Net Debt 2021 | 49.37M 3.95B | Net Debt 2022 | 44.87M 3.59B | EV / Sales 2022 | 4.45 x |
| P/E ratio 2021 |
-1.11
x | P/E ratio 2022 |
-0.47
x | Employees | 225 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -4.84% | ||
| 1 week | +14.56% | ||
| Current month | +104.36% | ||
| 1 month | +90.32% | ||
| 3 months | -4.84% | ||
| 6 months | -29.76% | ||
| Current year | -35.87% |
1 week
0.51
0.67
1 month
0.270.67
Current year
0.251.45
1 year
0.251.45
3 years
0.255.45
5 years
0.255.45
10 years
0.255.45
| Managers | Title | Age | Since |
|---|---|---|---|
James Walesa
CEO | Chief Executive Officer | 63 | 08/09/21 |
B. J. Parrish
DFI | Director of Finance/CFO | 53 | 08/09/21 |
Ginny Connolly
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Alan Channing
BRD | Director/Board Member | 80 | 08/09/21 |
James Walesa
CEO | Chief Executive Officer | 63 | 08/09/21 |
B. J. Parrish
DFI | Director of Finance/CFO | 53 | 08/09/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.59 | -4.84% | 10,239 |
| 25/04/24 | 0.62 | +3.33% | 2,028 |
| 23/04/24 | 0.6 | -1.32% | 2,774 |
| 22/04/24 | 0.608 | +18.06% | 2,936 |
| 19/04/24 | 0.515 | -0.96% | 5,309 |
Delayed Quote OTC Markets, April 26, 2024 at 07:14 pm
More quotes
Clearday, Inc. is engaged in providing technologies and care solutions. The Company has developed a purpose-built longevity-tech platform that addresses the pressing operational and care gaps in the longevity care market. Its platform leverages its longevity care experience in the challenging senior care venues (Memory and Alzheimer's treatment.) The Companyâs platform enables a dedicated connection between families and communities that can provide new insights, monitoring, and engagement opportunities through its numerous touchpoints, including live events and therapies, group calls, and management of OT/PT and treatment adherence. Its Clearday Labs develops products and services to support older Americans ability to age in the right place. The Clearday Labs initiatives include the development of digital and robotic services in its Longevity-tech platform. It provides exemplary care for older Americans facing dementia and other lifestyle-limiting physical and cognitive issues.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.87% | 15.96M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- CLRD Stock
